Anthrax immuneglobulin is a human immune globulin that is used in combination with antibiotics to treat anthrax. Anthrax immunoglobulin binds to protective antigen (PA) to prevent PA mediated cellular entry of anthrax edema factor and lethal factor.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Anthrax immunoglobulin is the active ingredient of these drugs:
United States
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):